Well I'm making logical conclusions. Here is where I'm getting my info:
1. The head of Sonic Labs (guys behind uMinn device) is working with Lenire.
2. I talked to
@kelpiemsp and he said he worked with the researchers who assume that selling it to them / letting them use it is the plan. It makes sense. Sonic Labs is a research team, they're more likely to sell the timing to an established company instead of starting their own business.
3. According to the clinical trials site, their final trials will be done and dusted by 2026/7 and they aim to commercialize soon after. I assume it will be easier for them to get through the FDA because by then their will be neuromodulation devices already on market.
If all this is true; then that can only mean Lenire is planning on releasing improved uMinn timings around the year 2027.